Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,668,072 papers from all fields of science
Search
Sign In
Create Free Account
hydroxycotinine
Known as:
1-methyl-3-hydroxy-5-(3-pyridyl)-2-pyrrolidinone
, 3'-Hydroxycotinine
, 3-Hydroxycotinine
Expand
A metabolite of nicotine that is detectable in the urine of smokers.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Cotinine
analogs & derivatives
Narrower (1)
trans-3'-hydroxycotinine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers
S. Murphy
,
Christopher J. Sipe
,
+4 authors
D. Hatsukami
Cancer Epidemiology, Biomarkers and Prevention
2017
Corpus ID: 3393638
Background: Tobacco exposure is often quantified by serum or saliva concentrations of the primary nicotine metabolite, cotinine…
Expand
2015
2015
POLYMORPHISM OF CYTOCHROME P 450 2 A 6 ( CYP 2 A 6 * 1 AND CYP 2 A 6 * 4 ) AMONG JAVANESE INDONESIAN SMOKER AND NON SMOKER
Christine Patramurti
,
Sugiyanto
,
A. Nurrochmad
,
S. Martono
2015
Corpus ID: 67845342
1.Postgraduate Programe Pharmaceutical Science, University of Gadjah Mada, 55281. Yogyakarta, Indonesia 2Faculty of Pharmacy…
Expand
2013
2013
High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial.
R. Schnoll
,
E. Wileyto
,
F. Leone
,
R. Tyndale
,
N. Benowitz
Nicotine & Tobacco Research
2013
Corpus ID: 33391660
INTRODUCTION Smokers with a faster rate of nicotine metabolism, estimated using the ratio of 3'-hydroxycotinine (3-HC) to…
Expand
Highly Cited
2011
Highly Cited
2011
Nicotine Metabolite Ratio Predicts Smoking Topography and Carcinogen Biomarker Level
A. Strasser
,
N. Benowitz
,
+5 authors
C. Lerman
Cancer Epidemiology, Biomarkers and Prevention
2011
Corpus ID: 25584641
Background: Variability in smoking behavior is partly attributable to heritable individual differences in nicotine clearance…
Expand
2011
2011
Validation of a liquid chromatography-tandem mass spectrometry method for the detection of nicotine biomarkers in hair and an evaluation of wash procedures for removal of environmental nicotine.
Eleanor I Miller
,
Gordon J Murray
,
D. Rollins
,
S. Tiffany
,
D. Wilkins
Journal of Analytical Toxicology
2011
Corpus ID: 37105546
The aim of this exploratory study was to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS-MS) method…
Expand
2007
2007
Prediction Methods for Nicotine Clearance Using Cotinine and 3-Hydroxy-Cotinine Spot Saliva Samples II. Model Application
M. Levi
,
D. Dempsey
,
N. Benowitz
,
L. Sheiner
Journal of Pharmacokinetics and Pharmacodynamics
2007
Corpus ID: 7960698
To develop and compare methods that predict individual nicotine (NIC) clearance, which reflects CYP2A6 activity, using random…
Expand
2002
2002
Genotyping human CYP2A6 variants.
Shari D Goodz
,
R. Tyndale
Methods in Enzymology
2002
Corpus ID: 31546973
1992
1992
Transdermal Nicotine
K. Palmer
,
M. M. Buckley
,
D. Faulds
Drugs
1992
Corpus ID: 46776565
SynopsisTransdermal nicotine delivery systems are a cigarette smoking cessation aid designed to deliver nicotine into the…
Expand
1990
1990
Synthesis of (3'R,5'S)-trans-3'-hydroxycotinine, a major metabolite of nicotine. Metabolic formation of 3'-hydroxycotinine in humans is highly stereoselective.
P. Jacob
,
A. Shulgin
,
N. Benowitz
Journal of Medicinal Chemistry
1990
Corpus ID: 24112362
A method for the synthesis of (3'R,5'S-trans-3'-hydroxycotinine, a major metabolite of nicotine in humans, is described. The…
Expand
Highly Cited
1972
Highly Cited
1972
Structure of hydroxycotinine, a nicotine metabolite.
E. Dagne
,
N. Castagnoli
Journal of Medicinal Chemistry
1972
Corpus ID: 11494767
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE